# Response Assessment During MR-guided Radiation Therapy for Glioblastoma

> **NCT05565326** · — · RECRUITING · sponsor: **University of Zurich** · enrollment: 20 (estimated)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DEVICE:** Low field (0.35 T) MR-images of the brain at a MRIdian® linac system

## Key facts

- **NCT ID:** NCT05565326
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05565326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05565326, "Response Assessment During MR-guided Radiation Therapy for Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05565326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*